Spectrum Pharmaceuticals Announces Filing of Thirteenth ANDA, for an Injectable
Spectrum Pharmaceuticals Announces Filing of Thirteenth ANDA, for an Injectable Drug, With the FDA (PR Newswire via Yahoo! Finance)
Spectrum Pharmaceuticals, Inc. announced that it has filed its thirteenth Abbreviated New Drug Application , which is for an injectable drug, with the U.S. Food and Drug Administration .